Effects of NMDA receptor antagonists on acute postoperative pain
Medicinska istrazivanja · 2025
DOI: 10.5937/medi0-58810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinska istrazivanja, 2025. Verfasst von Maja Stojanović und 3 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Introduction
Pain represents a multifactorial process with detrimental effects on the entire organism. This randomized, open-label pilot study investigated the effect of preemptive administration of ketamine and magnesium-sulfate on the intensity of postoperative pain after laparoscopic colon tumor resection.
Methods
Sixty patients were randomized into the ketamine-magnesium (KM) and the control (C) groups. After the introduction to anesthesia, patients in the KM group received an i.v. bolus dose of 0.5 mg/kg ketamine, followed by a continuous infusion of 0.6 mg/kg/h lasting until the end of surgery. After a bolus dose of ketamine, they also received magnesium-sulfate 20 mg/kg in an intravenous infusion (5-10 minutes). Group C received only 0.9% NaCl infusion. After the patients were awakened (0h), the pain intensity was compared (0-46h) between the two groups.
Results
The Mann-Whitney test implied significantly (p0.05) for VAS scores after 6, 14, 18, 38 and 46 hours, compared to C group. Ketamine and magnesium-sulfate significantly (p
Zitieren
APA
Stojanović, M., Stevanović, P., Vučković, S., & Savić, V. (2025). Effects of NMDA receptor antagonists on acute postoperative pain. Medicinska istrazivanja. https://doi.org/10.5937/medi0-58810
Vancouver
Stojanović M, Stevanović P, Vučković S, Savić V. Effects of NMDA receptor antagonists on acute postoperative pain. Medicinska istrazivanja. 2025. doi:10.5937/medi0-58810
BibTeX
@article{Stojanovi2025,
author = {Stojanović, Maja and Stevanović, Predrag and Vučković, Sonja and Savić, Vujović},
title = {Effects of NMDA receptor antagonists on acute postoperative pain},
journal = {Medicinska istrazivanja},
year = {2025},
doi = {10.5937/medi0-58810}
}
EUVIMED